Click image to enlarge
Severe Eosinophilic Asthma is a form of severe asthma linked to high levels of eosinophils, a type of white blood cell. While eosinophils normally help fight infections, too many of them can cause inflammation and swelling in the airways. This leads to breathing difficulties and frequent asthma attacks.
Common symptoms include coughing, wheezing, chest tightness, and shortness of breath, even when using regular asthma medications. Because of this, many patients require advanced treatments. New targeted therapies, known as biologics, are designed to lower eosinophil levels and help reduce flare-ups.
We are currently recruiting volunteers to participate in a clinical research study evaluating an investigational medication for Severe Eosinophilic Asthma. The study drug is provided at no cost, and participation does not affect your insurance. Compensation is available for time and travel.